ABCL
Abcellera Biologics Inc
Clinical-stage biotechnology company discovering and developing antibody-based medicines
CUSIP: 00288U106HealthcareUS1 holder
Recent Activity
2023Q3
1 sell
-48.1K shares
Maverick CapitalEXIT
-48.1K shares
Loading more activity...